An intelligent drug development paradigm can enable small pharma to implement an effective early drug development approach. Drug development is a risky business. For a drug entering Phase I clinical ...

The artificial classifications of the World Bank and IMF at best serve their limited institutional purposes ~ to determine ...

In addition to the most visible effects of Covid-19 — tragic deaths, lingering illness, economic turmoil, and more — the pandemic is affecting much that is out of the spotlight. One is research on the ...

We have a new set of development goals. This time they are the Sustainable Development Goals (SDGs) for 2030, to be hailed by yet another UN summit on September 25-27, within the framework of the 70th ...

Change has never been the word most associated with pharma. Irrespective of a record-breaking number of newly approved drugs over the last two years, a new report just out warns that continued growth ...

Pharmaceutical companies are seeing the development process in a new way, and that has major implications for service providers. The effort to improve the effectiveness of research and development ...